Aarti Pharmalabs shareholding, ₹2 dividend in 2026 update

Overview

Aarti Pharmalabs Ltd. has a set of recent investor-facing datapoints spanning shareholding percentages across quarters, a declared equity dividend event dated September 2026, and multiple share-price snapshots reported at different times. The information also includes company profile details, registered and plant addresses, and basic contact coordinates for investor communication.

At the same time, the share-price prints included in the provided dataset do not align with one another because they refer to different timestamps and, in one case, show a value of ₹0 with a 100% fall versus a prior close. Rather than treating these as a single continuous quote, investors should read them as separate data points captured from different screens or moments.

Share price snapshots show mixed prints

Several share-price values for Aarti Pharmalabs are stated in the provided text:

• “The current share price of Aarti Pharmalabs is Rs 859.7.”
• “Aarti Pharmalabs share price today stands at ₹865.2 as on at the close of the market.”
• Hindi snapshot: “आरती फार्मालैब्स की लाइव कीमत : ₹835.75… खुला… ₹837; इंट्रा-डे हाई/लो: ₹850/₹826.”
• Another timestamped line: “20 अगस्त, 2026 को आरती फार्मालैब्स शेयर की कीमत ₹835 है | 12:22”.
• A separate historical datapoint: “Aarti Pharmalabs share price is Rs 766.20 as on 08 May, 2026, 03:58 PM IST… down by 1.48%… previous share price… 788.45.”
• A line dated 01-09-2026 04:11 states: share price today is “₹0”, with a change of “₹-840.70 (-100.00%)” from a previous close of “₹840.7”.

Taken together, these prints indicate the dataset is mixing multiple quote snapshots. The only directly stated conclusion is that different sources or timestamps reported different prices, and one entry shows an apparent anomaly (₹0) against a prior close value.

Dividend schedule: ₹2 final on 15 Sep 2026

The dividend table included in the text lists an equity dividend event with the following details:

• Ex-date: 15 Sep, 2026
• Dividend amount: 2
• Dividend type: FINAL
• Record date: 15 Sep, 2026
• Instrument type: Equity Share

No other dividend amounts or dates are provided alongside this entry. As a result, the dataset supports only the existence of this stated ₹2 final dividend event for equity shares with the same ex-date and record date.

Shareholding pattern: investors and promoters

The dataset contains a quarterly table with a header showing Jun 2025%, Sep 2025%, Dec 2025%, Mar 2026%, and Jun 2026%. Under this, “investors” is shown at:

• Jun 2025: 56.28%
• Sep 2025: 57.12%
• Dec 2025: 56.90%
• Mar 2026: 56.92%
• Jun 2026: 57.14%

Separately, a “Promoter” row appears with a series of values shown as:

• Promoter: 44.3, 43.7, 42.9, 43.1, 43.1, 42.9

The promoter sequence is presented without the same visible date headers in the provided text snippet. So the figures can be reported as provided, but they cannot be reliably mapped to specific quarters beyond what is explicitly shown.

LIC and other named holders

The same quarter-formatted table lists specific holders and categories:

• “life insurance corporatio...” (interpretable only as the truncated name as displayed): 6.00%, 5.28%, 5.28%, 5.28%, 5.27% (from Jun 2025 through Jun 2026).
• “llp”: 0.15%, “-”, 0.20%, 0.22%, 0.28%.
• “nishant pradip shah”: 1.10% consistently across all shown quarters (Jun 2025 to Jun 2026).

These values indicate limited quarter-to-quarter movement for the LIC line item and a gradual rise for the “llp” category by Jun 2026, while the named individual remains unchanged in the displayed period.

What business Aarti Pharmalabs operates

Two descriptions of operations are included. One states Aarti Pharmalabs Ltd. is a manufacturer of pharmaceuticals and specialty chemicals in India, operating across active pharmaceutical ingredients (APIs), specialty chemicals, and pharma intermediates.

Another description positions Aarti Pharmalabs as a pharmaceutical manufacturer and service partner focused on “the active ingredients inside medicines, not the finished pills”, and adds that it is the world’s largest non-Chinese integrated producer of caffeine and other xanthine stimulants, alongside being a growing contract development and manufacturing partner for global drug innovators. The dataset also describes the company as focusing on APIs and xanthine derivatives, leveraging process chemistry expertise and scale-up engineering.

Incorporation and key locations

The text states:

• Aarti Pharmalabs Limited (APL) was incorporated on August 23, 2019.
• Head office address: 2nd Floor, 204, Udyog Kshetra, Mulund – Goregaon Link Rd, Mulund (W), Mumbai, Maharashtra, India.
• A site address is provided as Plot No 22/C/1 & 22/C/2, 1st Phase, GIDC, Vapi, Gujarat - 396195.
• Another line mentions “City Mumbai 400083, State Maharashtra” and a phone number “022-49186000”.

The dataset also contains an older founding reference stating the company “was founded in 1984”, but it separately and explicitly states APL was incorporated in 2019. Both statements are presented as-is in the source text.

Contact and investor information

The following contact coordinates are explicitly listed:

• Email: investorrelations@aartipharmalabs.com
• Website: http://www.aartipharmalabs.com

These are the only investor contact details included in the provided material.

Key numbers at a glance

Shareholding details table (Jun 2025 to Jun 2026)

Why these updates matter for investors

For shareholders tracking Aarti Pharmalabs, the dividend entry is a concrete corporate-action datapoint because it specifies the dividend amount (₹2), type (final), and the relevant dates (ex-date and record date both on 15 Sep 2026). This directly affects eligibility based on share ownership around the record date.

The quarter-by-quarter shareholding percentages provide another lens into ownership stability. In the provided table, the “investors” line remains in a narrow band around 56% to 57% across Jun 2025 to Jun 2026. The LIC line moves from 6.00% to 5.27% over the same period, while the “llp” line rises to 0.28% by Jun 2026, and the named holder “nishant pradip shah” remains at 1.10%.

What to watch next

The next scheduled event explicitly stated in the dataset is the final dividend dated 15 Sep 2026. Separately, readers should treat the various share-price prints as time-specific snapshots rather than a single live quote, especially where the dataset includes an anomalous “₹0” entry alongside other prices in the ₹800-₹860 range.

As more consistent market data becomes available, investors typically reconcile price, corporate actions, and shareholding changes against official exchange filings and company communications using the provided investor relations email and website.